Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT05257694
Eligibility Criteria:
Inclusion Criteria:
* patients with HCC (Ia, Ib, IIa stage) China liver cancer staging who underwent resection or ablation
* without macro-vascular invasion
* Child-Pugh A/B grade
* HCC is proved by pathological examination or two enhanced imaging
* CEUS (Sonovue or Sonozoid) images are performed two weeks before the operation
* Invasive biomarker or prognosis of HCC available
* CEUS images are included in at least three stages (Arterial phase, Portal phase, and Late phase)
Exclusion Criteria:
* postop follow-up loss or expired less than 3 months
* patients with co-malignancy
* poor images quality for analyzing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05257694
Study Brief:
Protocol Section:
NCT05257694